Skip to main content
. 2020 Sep 9;12(9):2563. doi: 10.3390/cancers12092563

Table 3.

Comparing malignancy rates and risk of aggressive features between nodules that did and did not undergo molecular genetic testing.

Features No Molecular Molecular p Value
Malignant
  • -

    Bethesda III

  • -

    Bethesda IV

94 (47.2)
83 (38.4)
105 (52.7)
133 (61.5)
0.001
0.092
Aggressive features
  • -

    Bethesda III

  • -

    Bethesda IV

12 (32.4)
4 (18.2)
25 (67.6)
18 (81.8)
0.011
0.004